Market Overview

AMAG Pharma Names Greg Madison Chief Commercial Officer

Share:
Related AMAG
Mid-Afternoon Market Update: Ariad Pharmaceuticals Surges On Acquisition News; Stage Stores Shares Slide
AMAG Pharmaceuticals Tanks After Raymond James Downgrade

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Greg Madison as executive vice president and chief commercial officer. Mr. Madison brings a wealth of hands-on commercial experience and extensive leadership skills to AMAG. He joins AMAG from Genzyme Corporation, where he spent the past 12 years in various commercial roles in their renal division, most recently as the division's vice president and general manager.

Posted-In: News Management

 

Related Articles (AMAG)

View Comments and Join the Discussion!